Literature DB >> 12873821

Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease.

Guido Colloredo1, Maria Guido, Aurelio Sonzogni, Gioacchino Leandro.   

Abstract

BACKGROUND/AIMS: In chronic viral hepatitis, liver biopsy is performed for assessing disease activity and fibrosis. In this study, we evaluated the impact of the size of liver biopsy on the grading and staging.
METHODS: We selected 161 liver biopsies from patients with chronic types B and C hepatitis on the basis of their length (> or =3 cm) and width (1.4 mm). Ishak scoring system was used for grading and staging. The score was blindly repeated reducing the length of the specimen from > or =3 to 1.5 cm and to 1 cm long and width from 1.4 to 1 mm.
RESULTS: Reducing the length of the biopsy led to an increase of cases with mild grades: 49.7% in > or =3 cm, 60.2% in 1.5 cm and 86.6% in 1 cm long specimens (P<0.001). Similarly, cases staged as having mild fibrosis significantly increased in the shorter specimens: 59% in > or =3 cm, 68.3% in 1.5 cm and 80.1% in 1 cm long specimens (P<0.001). As for the width, both grade and stage were significantly underscored in the 1 mm samples, regardless of their length.
CONCLUSIONS: Liver biopsy size strongly influences the grading and staging of chronic viral hepatitis. The use of fine needles should be discouraged in this setting.

Entities:  

Mesh:

Year:  2003        PMID: 12873821     DOI: 10.1016/s0168-8278(03)00191-0

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  176 in total

1.  Transjugular liver biopsy: how good is it for accurate histological interpretation?

Authors:  E Cholongitas; A Quaglia; D Samonakis; M Senzolo; C Triantos; D Patch; G Leandro; A P Dhillon; A K Burroughs
Journal:  Gut       Date:  2006-04-24       Impact factor: 23.059

2.  Liver fibrosis: natural history may be affected by the biopsy sample.

Authors:  M Guido; M Rugge
Journal:  Gut       Date:  2004-12       Impact factor: 23.059

Review 3.  Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis.

Authors:  Ken Shirabe; Yuki Bekki; Dolgormaa Gantumur; Kenichiro Araki; Norihiro Ishii; Atsushi Kuno; Hisashi Narimatsu; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2018-01-09       Impact factor: 7.527

4.  qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patients.

Authors:  Shuoyu Xu; Yan Wang; Dean C S Tai; Shi Wang; Chee Leong Cheng; Qiwen Peng; Jie Yan; Yongpeng Chen; Jian Sun; Xieer Liang; Youfu Zhu; Jagath C Rajapakse; Roy E Welsch; Peter T C So; Aileen Wee; Jinlin Hou; Hanry Yu
Journal:  J Hepatol       Date:  2014-02-26       Impact factor: 25.083

5.  3.0T 31P MR spectroscopy in assessment of response to antiviral therapy for chronic hepatitis C.

Authors:  Chun-Yu Zhang; Qian Zhang; Hui-Mao Zhang; Hai-Shan Yang
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

6.  Assessment of liver fibrosis by transient elastography in persons with hepatitis C virus infection or HIV-hepatitis C virus coinfection.

Authors:  Gregory D Kirk; Jacquie Astemborski; Shruti H Mehta; Chuck Spoler; Cedric Fisher; Danisha Allen; Yvonne Higgins; Richard D Moore; Nezem Afdhal; Michael Torbenson; Mark Sulkowski; David L Thomas
Journal:  Clin Infect Dis       Date:  2009-04-01       Impact factor: 9.079

7.  Evaluation of the aspartate aminotransferase/platelet ratio index and enhanced liver fibrosis tests to detect significant fibrosis due to chronic hepatitis C.

Authors:  John R Petersen; Heather L Stevenson; Krishna S Kasturi; Ashutosh Naniwadekar; Julie Parkes; Richard Cross; William M Rosenberg; Shu-Yuan Xiao; Ned Snyder
Journal:  J Clin Gastroenterol       Date:  2014-04       Impact factor: 3.062

8.  Liver biopsy for parenchymal liver disease - is routine real time image guidance unnecessary?

Authors:  Anil John; Saad Al Kaabi; Madiha Emran Soofi; Muneera Mohannadi; Salva Manam Kandath; Moataz Derbala; Rafie Yakoub; Esra Mohammed Al-Ahdal; Manik Sharma; Hamid Wani; Nazeeh Dweik; Anjum John; Mohammed Tariq Butt
Journal:  Indian J Gastroenterol       Date:  2013-09-19

9.  Influence of liver biopsy heterogeneity and diagnosis of nonalcoholic steatohepatitis in subjects undergoing gastric bypass.

Authors:  Janani Arun; Niraj Jhala; Audrey J Lazenby; Ronald Clements; Gary A Abrams
Journal:  Obes Surg       Date:  2007-02       Impact factor: 4.129

10.  Routine ultrasound-guided liver biopsy versus echo-assisted procedure in viral chronic hepatitis.

Authors:  R Chiavaroli; P F Grima; P Calabrese; P Grima
Journal:  Radiol Med       Date:  2008-09-25       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.